History of Cannabis in the Czech Republic: Legislation until 1950

08/05/2020 Author: Tadeáš Kouřil 9 min read

How Cannabis Attitudes Have Changed Over Time in the Czech Republic

We will try to map the history of public attitude towards this plant. We will highlight the most important milestones and describe the current state as well as expected developments that are being discussed in the political sphere.

Legal status of cannabis in the European Union (as of 25 September 2026)

The EU has no single cannabis law: it sets a common framework for hemp farming, trade and drug trafficking, while recreational use is regulated by each Member State.
CBD lawfully produced in one Member State may in principle be sold in another; a national ban is allowed only if it is suitable to protect public health and does not go beyond what is necessary. The Court held that such CBD is not a narcotic drug under the 1961 Single Convention (Articles 34 and 36 TFEU, Case C-663/18 Kanavape, paras 76 and 96).
Industrial hemp qualifies for CAP direct payments only if the THC content of the variety does not exceed 0.3 % (Art. 4(4) Regulation (EU) 2021/2115); THC control methods are set by the Commission (Art. 60(4)(a) Regulation (EU) 2021/2116).
Member States may restrict how hemp is grown, for example ban indoor hydroponic cultivation, if the restriction is suitable and proportionate for protecting public health (Case C-793/22 Biohemp Concept, 4 October 2024).
Member States must make intentional unlawful cultivation of cannabis plants and drug trafficking a criminal offence (Art. 2(1)(b) Framework Decision 2004/757/JHA, as quoted in Case C-271/23).
Rules on recreational cannabis differ widely: Germany allows adults to possess up to 25 g in public, 50 g at home and three plants (§ 3 and § 9 KCanG), while in Czechia personal use becomes a criminal offence only above 5 plants, 200 g at home or 50 g elsewhere, and plants with up to 1 % THC are excluded (§ 285 Czech Criminal Code).

“Články 34 a 36 SFEU musí být vykládány v tom smyslu, že brání vnitrostátní právní úpravě, která zakazuje uvádět na trh CBD, který je legálně vyprodukován v jiném členském státě, v případě, že je extrahován z celé rostliny cannabis sativa, a nikoli pouze z jejích vláken a semen, ledaže je tato právní úprava s to zaručit naplnění cíle ochrany veřejného zdraví a nepřekračuje meze toho, co je k dosažení tohoto cíle nezbytné.”
[Translation: “Articles 34 and 36 TFEU must be interpreted as precluding national legislation which prohibits the marketing of CBD lawfully produced in another Member State when it is extracted from the Cannabis sativa plant in its entirety and not solely from its fibre and seeds, unless that legislation is appropriate for securing the attainment of the objective of protecting public health and does not go beyond what is necessary for that purpose.”]
Court of Justice of the European Union, 19 November 2020, Case C-663/18 (Kanavape)

This overview is based on legislation and case law in the legal database Europaius. It is not legal advice.

The Historical Evolution of Cannabis in the Czech Republic: From Industrial Plant to Collector's Genetic Material

Cannabis has been part of European history for millennia, and the Czech Republic is no exception. This fascinating plant has undergone a radical transformation in its social perception and legal framework, evolving from a valuable industrial raw material into an object of genetic study and specialized collecting. For enthusiasts of collector seeds, understanding this historical evolution is essential to appreciating the genetic wealth we are able to preserve today.

Ancient Origins: Cannabis as an Industrial Resource

Archaeological finds in Czech territory reveal a relationship with this plant going back millennia. In the Moravian town of Mohelnice, hemp fiber textiles estimated to be 5,000 years old were discovered, showing the deep understanding ancient civilizations had of the properties of these genetics.

For centuries, cannabis was an integral resource for Czech communities. Fibers were turned into textiles of various styles and uses, while seeds were cold- and hot-pressed to extract nutritious oils and fuel. The leftover material served as animal feed, and even the roots were used as a charcoal fuel. This complete use of the plant shows the deep respect and understanding that existed for the potential of different cannabis phenotypes.

It is fascinating to see how young girls learned spinning techniques from the age of five or six, passing down knowledge about handling these genetics from generation to generation. This tradition represents one of the earliest examples of practical preservation of cannabis genetic material in Central Europe.

Legal Transformation: From Industrial Resource to Regulation

The perception of cannabis underwent a radical transformation during the 20th century. Until 1950, these genetics were regulated solely as an industrial crop, with no consideration given to their psychoactive properties. The plant was valued exclusively for its fibers and nutritious seeds, and there were no restrictions on possessing or processing it.

The turning point came after the Second World War, when Czech legislation began to distinguish between different varieties. Penal codes 197 and 198 of law 86/1950 introduced the first restrictions, although they initially applied only to Cannabis indica, later extending to other genetic subtypes.

Evolution of the Regulatory Framework (1962-2009)

Criminal law 140/1961 established a legal framework that lasted almost five decades, with numerous amendments. This period was marked by the gradual differentiation between industrial cannabis and varieties with specific chemical profiles. A crucial provision specified that cannabis grown exclusively for industrial and horticultural purposes was not considered a controlled substance, keeping the fiber-growing tradition alive.

The most significant reforms included:

Reform 175/1990: A precise definition of "addictive substance", including alcohol, psychotropic substances, and compounds capable of influencing human cognitive abilities.
Amendment 112/1998: The establishment of specific quantitative limits for different cannabis preparations, with criteria based on THC content and the weight of dried material.

Medical Cannabis: A New Scientific Paradigm

April 1, 2013 marked the most significant milestone in the modern history of Czech cannabis with the legalization of medical cannabis. This legislation officially recognized the therapeutic properties of certain genetics with specific cannabinoid contents, establishing a scientific framework for their study and application.

The creation of the State Agency for Medical Cannabis (SAKL) under the State Institute for Drug Control represented a professional approach to researching cannabinoid profiles. This agency manages specialized licenses and oversees the distribution of genetic material authorized for medical research.

The implementation process revealed the complexity of working with these specialized genetics. The first cannabis medicines reached Czech pharmacies in 2016, three years after legalization, showing the technical challenges involved in the professional handling of this genetic material.

International Suppliers and Specialized Genetics

During the establishment phase, Canadian companies such as Canopy Growth Corporation and Tilray provided specialized genetics, each with unique terpene and cannabinoid profiles. These international collaborations enriched local knowledge of the genetic diversity available for medical research.

In 2018, the Czech company Elkoplast Slušovice began producing local genetics, establishing homegrown research lines that combine historical traditions with modern technology. This initiative represents a return to the historical roots of Czech cannabis, but with a contemporary scientific approach.

The Future of Cannabis Genetic Collecting

For collectors specializing in cannabis genetic material, Czech history offers unique perspectives on preserving traditional varieties and developing new genetic lines. The transition from industrial use to specialized applications shows the importance of conserving genetic diversity.

Today's collector seeds represent centuries of selection and adaptation, preserving traits that could otherwise be lost without the conscious effort of dedicated collectors. Each variety holds unique genetic information about climate resistance, aroma profiles, and cannabinoid composition, constituting an invaluable scientific heritage.

The Czech experience illustrates how traditional knowledge can be complemented by modern research, creating new opportunities for the study of terpenes, flavonoids, and other aromatic compounds that define the unique characteristics of each genetic line. For collecting enthusiasts, this means access to an increasingly diverse and scientifically documented genetic heritage.